California Voters Divided in Support of Ballot Measure That Would Fund Stem Cell Research
By Kaiser Daily Women's Health Policy Report,
Kaiser Daily Women's Health Policy Report
| 08. 16. 2004
California voters are "almost evenly divided" on a ballot measure that would provide the state with nearly $3 billion in funding for human embryonic stem cell research, according to a Field Poll survey released on Sunday, Reuters reports (Reuters, 8/15). Under the measure, which will appear on the Nov. 2 ballot as Proposition 71, the California Stem Cell Research and Cures Initiative, organized by Californians for Stem Cell Research and Cures, would provide $295 million in state funds annually for 10 years to California schools, institutes and companies that conduct embryonic stem cell research. The initiative would provide grants and loans to organizations that use stem cells derived from human embryos that are less than two weeks old. The measure also would create a 29-member panel -- appointed by the governor, University of California chancellors and other officials -- that would determine allocation of the grants, which would be provided only to California organizations. If the ballot measure is successful, California would become the first state to publicly fund embryonic stem cell research, which some scientists believe...
Related Articles
By Carl Zimmer and Marco Hernandez , The New York Times | 07.01.2026
Scientists have long dreamed of discovering the alchemy by which chemicals can be turned into life. On Wednesday, a team at the University of Minnesota announced that it had taken a major step toward that vision.
Blending together dozens of...
By Marisa Flook , BioNews | 06.29.2026
An anti-ageing gene therapy not approved by the US Food and Drug Administration (FDA) is set to be offered by an American company at overseas clinics outside of US jurisdiction.
The treatment, developed by Minicircle from Austin, Texas, uses a...
By Ed Pilkington, The Guardian | 06.12.2026
Desperate US parents paying up to $20,000 a session for a procedure scientists say could be bogus
Autistic children as young as 18 months old are being injected with human stem cells derived from umbilical cords in unapproved, unproven and...
By Tobi Thomas, The Guardian | 06.10.2026
The UK’s stem cell transplant system is potentially putting the lives of blood cancer patients at risk as a result of inadequate infrastructure and a lack of long-term planning, a parliamentary report has found.
A hematopoietic stem cell transplant, often...